Back to Our Lawyers

Sharon Ki

Associate Director, Dispute Resolution

Download CV

Practice Areas

Qualifications

  • Queen Mary University of London, LLB (Hons) (2016)
  • Advocate & Solicitor of the Supreme Court of Singapore (2019)
Overview

Sharon practises commercial litigation and arbitration, with a focus on complex cross-border disputes. She represents clients at all levels of the Singapore Courts and in international arbitration proceedings.

Sharon advises clients across a broad range of industries including life sciences, technology, international trade, oil & gas, banking, and trade finance, allowing her to bring a commercially attuned and well-rounded perspective to each matter. She is also experienced in securing urgent relief such as interim proprietary injunctions and freezing orders in high-stakes, time-sensitive matters.

Known for her solutions-focused and pragmatic approach, Sharon is committed to delivering practical outcomes in challenging disputes.

  • Secured an interim proprietary injunction over digital assets valued over SGD 220 million - Acted for a group of Chinese corporate entities and their ultimate beneficial owner in securing a high-value interim proprietary injunction over digital assets valued over SGD 220 million. The assets had been wrongfully diverted from our clients’ control and the matter involved urgent cross-border tracing and recovery efforts in the digital asset space.
  • Acting in a high-value commercial litigation involving a USD 112 million professional negligence claim against the former auditors of an insolvent principal local subsidiary of one of Denmark’s largest listed oil trading company - The claim concerns alleged audit failures in respect of the financial statements for the period leading up to the subsidiary’s insolvency and involves complex issues of auditor liability and the contributory negligence of the company’s former directors.
  • Acting for Singapore-headquartered biopharmaceutical firm listed on the Korea Exchange in a high-value SIAC arbitration for breach of contract and conspiracy - Representing a Korean biopharmaceutical firm in an SIAC arbitration arising out of an alleged breach of a commercial manufacturing agreement for a Covid-19 vaccine valued at approximately USD 750 million. The dispute also involves claims in unlawful means conspiracy and raises complex issues of cross-border life sciences regulation and pandemic-era supply chain disruption.
  • Successfully represented a commodities trading company in an SIAC arbitration commenced by a Singapore-listed financial services institution - Secured a favourable award dismissing the claim, which concerned receivables allegedly assigned under trade financing arrangements, in full. The matter involved complex issues of assignment, title to receivables, and the interplay between trade documentation and financing structures in cross-border commodities transactions.
  • Advised on third-party funding arrangements for litigation - Advised the security agent of a consortium of secured creditors in connection with the sale and assignment of a litigation claim held by an insolvent company to an unrelated third party. The matter raised novel and nuanced issues under Singapore law concerning the doctrines of maintenance and champerty, including the scope of their exceptions in the context of insolvency and commercial litigation funding.
  • Member, Law Society of Singapore
  • Member, Singapore Academy of Law